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A B S T R A C T
Alcohol use disorders (AUD) are often comorbid with other disorders with high levels of impairment, which is of
relevance for the development and the progression of the disease. Evidence shows that AUD varies greatly with
regard to its aetiology, which might lead to distinct clinical representations with important implications for
treatment. The current study aimed to apply latent class analysis (LCA) techniques to investigate how co-
morbidity patterns in AUD vary with regard to specific explanatory factors. A Swiss community sample of
N=439 individuals with AUD was subjected to LCA in order to find empirical AUD subtypes of comorbid
psychiatric conditions. The subtypes were further validated based on a range of external criteria, including
clinical and psycho-social factors as well as treatment variables. A three-class solution of empirical subtypes of
AUD comorbidity (low, depressive-anxious, and drug-dependent antisocial) provided the best fit to the data. The
three AUD subtypes showed homogeneous comorbidity patterns but varied along dimensions of psycho-social
risk factors, consumption patterns and consequences as well as treatment history. Our findings provide strong
evidence that AUD in non-treated samples can be described as a multidimensional disorder in terms of its
comorbidity structure with distinct etiological factors and important consequences for treatment.
Introduction
Excessive alcohol consumption is a risk factor for a number of health
problems and a higher mortality; it ranges at the eighth position of
leading causes for death and represents the third-leading risk factor for
disease and disability worldwide (WHO, 2011). According to the Global
Status Report on Alcohol and Health of the World Health Organization
(WHO) of the year 2014, Europe was the most affected continent with a
global mean prevalence of 7.5% (versus 4.1% worldwide) of alcohol use
disorders (AUD) (WHO, 2014). The variability of prevalence between
European countries was high, whereof Switzerland belonged to those
countries that rank above the European average with almost twice as
high prevalence as the global mean (WHO, 2014). Indeed, almost one
fifth (18%) of the Swiss population were estimated to suffer from AUD
at least once during their lives (Angst et al., 2006). However, as sug-
gested by large community studies, there are only a small proportion of
those with AUD that actually sought treatment for their problems
(Alonso et al., 2004; Wu et al., 2007). This might be problematic since
AUD is associated with significantly impaired functioning, which has
important consequences for society and represents an enormously high
socio-economic burden (Grant et al., 2015; Rehm et al., 2009).
In general, males are diagnosed with AUD approximately twice as
often as females (Sher et al., 2005) but there also other factors that are
frequently linked to a higher risk of AUD, such as genetic
(Mayfield et al., 2008) and environmental factors (Barnow et al., 2002;
Rose et al., 2003). Often related to these factors but also independent,
an early initiation of regular or heavy drinking may lead to more and
heavier symptoms due to longer periods of consumption (Hingson et al.,
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2006).
AUD is also associated with a broad range of comorbid mental
health problems – either as causal factors or as a consequence
(Falk et al., 2008; Flensborg-Madsen et al., 2009; Kessler et al., 1997).
Evidence from large epidemiological studies has shown that AUD is
frequently associated with other psychiatric conditions, including de-
pression, anxiety disorders as well as personality disorders, poly-
substance misuse and suicidality (Briere et al., 2014; Cullen et al., 2013;
Fuehrlein et al., 2016; Glass et al., 2014; Pacek et al., 2013). However,
large heterogeneity among individuals with AUD has been recognized
with respect to clinical and also etiological factors, which largely affects
the treatment process and its outcome (Wu et al., 1999). Initial attempts
to classify individuals with AUD suggested binary typologies that pri-
marily posit the distinction between mild and severe forms of AUD
(Leggio et al., 2009). However, in order to account for the broader
clinical and etiological variation among individuals with AUD alter-
native models suggested typologies ranging to up to five AUD subtypes
that added evidence for the distinction of internalizing (e.g. mood and
anxiety) and externalizing (e.g. antisociality and substance use) phe-
notypes in AUD (Leggio et al., 2009), although a mix of both is possible
as well (Chan et al., 2008; Dawson et al., 2010). In fact, all typologies
more or less agreed that AUD with comorbid internalizing psycho-
pathology is associated with greater AUD severity and impairment,
suicidal behaviour, and predominantly female gender (Bolton et al.,
2006; Briere et al., 2014; Dawson et al., 2010; Schneier et al., 2010).
Those individuals typically used alcohol to relieve boredom and
symptoms of depression and anxiety, subsequently developed persistent
alcohol dependence and were more likely to seek help for their pro-
blems than others (Mojtabai et al., 2002). Alcoholics with comorbid
externalizing psychopathology, in contrast, were rather young and
male, clinically more severe, alcoholics with early-life drinking onsets
that, however, received treatment for their problems less often and if
so, with poorer treatment success than others (Goldstein et al., 2010;
Kranzler et al., 1996).
Therefore, a subtype-based representation of AUD might provide
insight into underlying mechanisms of differential treatment responses,
which allow targeting these differences in the treatment process, but
also highlight the need for early identification and referral for these
problems. However, most research on AUD subtyping stems from
clinical studies while data from non-treatment seeking samples is rather
limited (Windle and Scheidt, 2004). There is, however, epidemiological
support from several large community studies that Switzerland has a
largely distinct prevalence of common mental disorders (Ajdacic-
Gross et al., 2016; Angst et al., 2005; Rodgers et al., 2015;
Vandeleur et al., 2017) than that reported elsewhere (Kessler et al.,
2005; Martin, 2003). To our knowledge, this is the first study that ex-
amined AUD subtypes with respect to their comorbidity profiles in the
Swiss population.
Thus, this study aimed to develop a population-based typology of
AUD comorbidity based on a representative non-helpseeking general
population sample of Swiss individuals with AUD. These subtypes were
further validated with a range of external criteria, including socio-
demographic, clinical, and psychosocial factors. Therefrom, we hope to
gain insight into the discrepancy between common treatment needs and
mental health care patterns that might be shared by individuals of a
specific subtype, which is essential for successful clinical practice as
well as future research on etiology, prevention and treatment.
Methods
2.1. Sample and procedure
All data were collected within the PsyCoLaus study (Preisig et al.,
2009), a subsample from the larger CoLaus study (Firmann et al.,
2008), a randomly selected population-based cohort study conducted in
Lausanne, in the French-speaking part of Switzerland. From 2003 to
2006, a community sample of N=6,734 subjects aged between 35 and
75 years was recruited for the first wave of CoLaus, which was designed
to assess the prevalence and determinants of cardiovascular risk factors
and diseases. Sixty-seven percent of the subjects of the CoLaus study in
the age range between 35 and 66 years (N=3,720) accepted to parti-
cipate in the psychiatric exam (PsyCoLaus; see Preisig et al. 2009) for a
detailed description). From this sample, about half (53.0%) were female
and the mean age of the subjects was 50.9 years (SD=8.80).
For the purpose of the current study, the sample was restricted to
those participants meeting lifetime criteria for AUD (N=439; 11.8%).
From those, 22.6% were females and the mean age was 50.5 years
(SD=8.6). The majority of participants were married (54.4%) and had
basic education (59.2%) (i. e. completion of basic schooling until the
age of 16 years, after which either an apprenticeship was undertaken or
a professional school was attended). Socio-economic status (SES) was
assessed according to the Hollingshead's index (Hollingshead, 1975).
The mean SES was 3.3 (SD=1.3), indicating a middle class status on
average. For more detailed information on sociodemographic char-
acteristics please refer to Table 4.
Interviewers were required to be at least bachelor-level psycholo-
gists, and were trained over a one- to two-month period. During data
collection, each interview was reviewed by an experienced senior
clinical psychologist. The study was approved by the Ethics Committee
of the University of Lausanne, Switzerland. All participants provided
written consent after being informed of the goal and funding of the
study.
2.2. Measures and variables
The data of the PsyCoLaus study were derived from the French
version (Leboyer et al., 1995) of the semi-structured Diagnostic Inter-
view for Genetic Studies (DIGS) (Nurnberger et al., 1994). In addition
to demographic features, the French version of the DIGS comprises
information on a broad spectrum of DSM-IV Axis I and Axis II criteria
(including AUD, which comprised both abuse and dependence) as well
as on suicide behavior and antisocial personality disorders (ASP)
(Preisig et al., 2009). PTSD and generalized anxiety disorders were
assessed using the relevant sections from the French version
(Leboyer et al., 1991) of the Schedule for Affective Disorders and
Schizophrenia – Lifetime and Anxiety disorder version (Endicott and
Spitzer, 1978). In addition, the brief phobia chapter of the DIGS was
replaced by the corresponding more extensive chapters of the SADS-LA
which elicit information on agoraphobia with or without panic attacks,
social and specific phobias. Psychiatric diagnoses were all considered
with lifetime prevalence. Our DIGS version revealed excellent inter-
rater reliability in terms of kappa or Yule's Y coefficients for depressive
disorders (0.93;Preisig et al., 1999), SUD (range: 0.88-0.97) or ASP
(0.97) (Berney et al., 2002), whereas the 6-week test-retest reliability
was lower but still acceptable: (Depressive disorders 0.67; SUD range
0.48-0.91; ASP 0.64; Berney et al., 2002; Preisig et al., 1999). The
French version of the anxiety sections of the SADS-LA revealed fair to
good test-retest reliability (range 0.43-0.66; Leboyer et al., 1991),
whereas in our own reliability study we documented perfect inter-rater
agreement for all specific anxiety disorders except for agoraphobia
(Yule's Y = 0.96) and fair to good 6-week test-retest reliability (range
0.44-0.77) for all anxiety disorders (Rougemont-Buecking et al., 2008).
The following categories, based on the DSM-IV criteria, were con-
sidered as comorbid conditions of AUD: substance use disorder (abuse
or dependence) of cannabis, cocaine, and other substance-related dis-
orders (narcotics, sedatives, stimulants, hallucinogens combined due to
low prevalence), major depressive disorder, simple phobia, social
phobia, PTSD, separation anxiety disorder, and other anxiety disorders
(agoraphobia, generalized anxiety disorder, and panic disorder com-
bined due to low prevalence), ADHD, antisocial personality disorder,
and suicide attempts.
Participants were further asked about chronically adverse or
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dysfunctional environments during childhood, such as whether they
had had an unhappy childhood, had feared to be punished by their
parents, had been placed in a foster home, whether they ever ran away
from home, had not been raised by their biological parents, or had had
divorced or separated parents during their childhood. A further ques-
tion on income during adulthood documented the amount per annum
which was dichotomized into lower or higher than CHF 50,000.
Furthermore, participants were asked whether they had first degree
relatives with relevant mental health problems (AUD, SUD, depression,
anxiety disorders). Then, alcohol-related variables documented con-
sumption patterns (age of AUD onset, the average amount of alcohol
intake in grams per day and whether alcohol was consumed to relieve
symptoms of psychological distress), problems and consequences of
alcohol consumption (indicators of harmful use such as the experience
of alcohol-related blackouts and binge-drinking sessions as well as
physical and social consequences). Health-related functioning over the
lifespan was assessed in two ways – first by a single item question on
functional impairment in areas of work, school or daily life responsi-
bilities and, second, by the Global Assessment of Functioning (GAF)
score. The GAF score was assigned according to the definition in the
DSM-IV manual, and provides an interviewer assessment of the severity
and the duration of all psychiatric symptoms that affected the subject's
psychological, social and occupational functioning over the lifespan.
Then, information on treatment was obtained for general mental
health problems, such as the utilization and age of first professional
treatment, hospitalization and age of first admission and use of psy-
chotropic medication as well as alcohol-specific treatment – overall as
well as separately for professional and non-professional (Alcoholics
Anonymous or others) help-seeking.
All alcohol- and treatment-related variables except self-medication
were based on single items from the DIGS. Self-medication of psycho-
logical distress was indexed by endorsing the question of whether al-
cohol was used to relieve the symptoms surveyed in any diagnostic
section of the DIGS at least once.
Statistical considerations
Prevalences of comorbid conditions were provided for the study
sample and compared to those from the overall PsyCoLaus sample in-
cluding subjects who were not included in the current study. Chi-square
test statistics were calculated and p-values were Bonferroni-corrected.
Latent class analysis (LCA) was used to identify distinct comorbidity
patterns in the sample of individuals diagnosed with AUD. This meth-
odological procedure allows identifying homogeneous groups of in-
dividuals based on similar patterns of comorbid conditions. Model
building was conducted in two steps: first, an unconditional model was
run followed by a conditional model, which was accounted for by sex,
age and amount of daily alcohol intake as covariates to the latent class
variable. Fit statistics that allow testing for multiple class solutions were
computed. Accordingly, starting with a single (full sample) class solu-
tion, we tested solutions with increasing numbers of classes (up to five
classes) in each of the three steps described above. We evaluated the
relative fit of different models using the Bootstrapped Likelihood Ratio
Test (BLRT; (McLachlan and Peel, 2000), the Lo–Mendell–Rubin ad-
justed likelihood ratio test (LMR-A; (Lo et al., 2001), the Bayesian in-
formation criterion (BIC) and the sample-size-adjusted BIC (BIC-A), and
the Akaike information criterion (AIC; (McLachlan and Peel, 2000).
Significant LMR-A and BLRT values suggest that a model is preferable
over another model with the next lower number of classes. A non-sig-
nificant LMR-A or BLRT value indicates that the solution includes too
many classes (Nylund et al., 2007). Lower values of BIC, AIC and BIC-A
for a given model indicate an improved model fit relative to another
model with more or less classes. Conditional probabilities for each la-
tent class indicator were calculated via thresholds using the following
formula:
= +Prob class exp class threshold( ) 1/(1 ( ))
Descriptive statistics for socio-demographics, risk and otherwise
related factors were calculated for the study sample as well as for
stratified AUD comorbidity subtypes. Chi-square tests for categorical
variables and One-way-analyses of variance (ANOVA) for continuous
variables were used to test for differences across classes. P-values of
class comparisons were table-wise (by domain of predictor), adjusted
using the Bonferroni correction.
LCAs were conducted using MPlus v6 (Muthen and Muthen, 1998-
2011). Information on class membership for each case was saved to a
separate file, which was then imported to STATA/SE 12
(StataCorp, 2011) and merged with basic data for further processing.
All subsequent analyses were conducted using Stata/SE 12.
Results
Table 1 displays the prevalence of those psychiatric conditions
considered as comorbid disorders in AUD for the entire PsyCoLaus
sample – stratified for having AUD (our current study sample) versus
not having AUD. In the full sample the most prevalent condition was
major depression, followed by simple and social phobia, other anxiety
disorders and suicidality. Except for depression, which was comparable,
all other psychiatric conditions were more frequent in individuals with
AUD (lowest prevalence 5%) than in those without AUD (lowest pre-
valence < 1%), for which substance use disorders, PTSD, ADHD, an-
tisocial personality disorder and suicide attempts significantly differed
(for more details please refer to Table 1).
LCA modelling of AUD comorbidity revealed the following results.
The unconditional model clearly revealed two classes according to BIC
and LMR (not tabulated). After adding covariates (sex, age and amount
of daily alcohol intake) to the latent class variable, the model fit
Table 1
Lifetime prevalence of comorbid conditions in the PsyCoLaus baseline sample and in the subsample of 439 individuals with AUD versus those without AUD.
Total sample N=3,720 No AUD N=3,281 AUD N=439 p-value
n(%) n(%) n(%)
Cannabis use disorder 201 (5.4) 119 (3.6) 82 (18.7) <0.001
Cocaine use disorder 67 (1.8) 37 (1.1) 30 (6.8) <0.001
Other drug use disorders 56 (1.5) 29 (0.9) 27 (6.2) <0.001
Major depression 1,626 (43.7) 1,437 (43.8) 189 (43.1) 0.768
Simple phobia 587 (15.8) 520 (15.9) 67 (15.3) 0.751
Social phobia 444 (11.9) 376 (11.5) 68 (15.5) 0.014
Posttraumatic stress disorder 147 (4.0) 116 (3.5) 31 (7.1) <0.001
Separation anxiety disorder 203 (5.5) 172 (5.2) 31 (7.1) 0.115
Other anxiety disorders 329 (8.9) 288 (8.8) 41 (9.3) 0.699
Attention deficit hyperactivity disorder 96 (2.6) 74 (2.3) 22 (5.0) 0.001
Antisocial personality disorder 96 (2.6) 51 (1.6) 45 (10.3) <0.001
Suicide attempt 221 (5.9) 168 (5.1) 53 (12.1) <0.001
Note: Bold values are statistically significant after Bonferroni's correction.
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improved substantially. Fit indices for the 1-5 competing latent class
models are provided in Table 2. Accordingly, the BIC was at its
minimum with three classes while the AIC and the sample-size-adjusted
BIC indicated the best fit with the four-class model. The LMR indicated
an improvement up to the three-class and the BLRT up to the four-class
solutions. In the case of a disagreement between BLRT and LMR, it was
recommended to rely on BIC for deciding on the number of latent
classes (Nylund et al., 2007). Therefore, we finally decided to keep the
three-class solution of AUD subtypes for further analyses (see Figure 1).
Table 3 displays the conditional probabilities of the three latent
classes of AUD comorbidity. Class 1 (N=46) was specifically featured
by medium to high probabilities of comorbid polydrug misuse and
antisocial personality disorder; class 2 (N=120) was specifically asso-
ciated with major depression and most anxiety disorders (despite
higher probabilities, social phobia and PTSD were not statistically dif-
ferent from class 1); ADHD and suicidality were linked to both classes 1
and 2 at lower levels. Class 3 (N=273) contains those cases with low
probabilities for almost all comorbid conditions. According to this, we
labeled class 1 as the drug-dependent antisocial (DD-AS), class 2 as the
depressed-anxious (DEP-ANX), and class 3 as the low comorbidity AUD
subtype (LOW). For the sake of comprehensibility we have rearranged
the order of subtypes (classes) for subsequent analyses as follows: 1.
LOW, 2. DEP-ANX, and 3. DD-AS.
AUD subtypes differed in a number of socio-demographic char-
acteristics (Table 4). While more than two-thirds from the DEP-ANX
and one-third from the DD-AS subtype were females, almost all mem-
bers from LOW were male (except for one subject). Members from DD-
AS were younger than the others, followed by DEP-ANX and finally
LOW with the highest mean age. Subjects from LOW were more often
married than single compared to the other subtypes. Subtypes did not
differ significantly regarding education and SES.
Table 5 displays the prevalence of early developmental and psy-
chosocial risk factors, as well as familial liability for mental health
problems across classes of AUD comorbidity. Overall, to mention the
most prevalent factors, more than one third of the sample had grown up
with no biological parent, more than 40% had a first degree relative
Table 2
LCA fit statistics for the tested class solutions.
1 2 3 4 5
Class Classes Classes Classes Classes
AIC 12108.524 3533.090 3436.984 3417.688 3439.342




12124.922 3558.598 3477.067 3472.347 3508.577
LMR-LRT na 230.077 128.107 51.293 18.044
p = 0.001 p = 0.002 p = 0.072 p = 0.553
Parametric
BLRT
na 230.077 128.107 51.293 18.044
p < 0.001 p < 0.001 p < 0.001 p = 0.600
n for each class C1 = 439 C1 = 393 C1 = 46 C1 = 16 C1 = 39
C2 = 46 C2 = 120 C2 = 44 C2 = 61
C3 = 273 C3 = 200 C3 = 64
C4 = 197 C4 = 32
C5 = 243
Note: AIC = Akaike Information Criterion, BIC = Bayesian Information
Criterion, BLRT = Bootstrapped Likelihood Ratio Test; LMR-LRT = Lo-
Mendell-Rubin adjusted Likelihood Ratio Test; C1 = class 1; C2 = class 2;










CanUD CocUD OthUD MDD SIM SOC PTS SEP OAD ADH APD SUI
Class 1: DD-AS (n=46; 10.5%)
Class 2: DEP-ANX (n=120; 27.3%)
Class 3: LOW (n=273; 62.2%)
Fig. 1. Three class solution of AUD comorbidity
Note: CanUD=Cannabis use disorder; CocUD=Cocaine use disorder; OthUD=Other use disorders; MDD=Major depression; SIM=Simple phobia, SOC=Social
phobia; PTS= Posttraumatic stress disorder; SEP=Separation anxiety disorder; OAD=Other anxiety disorders; ADH= Attention deficit hyperactivity disorder;
APD=Antisocial personality disorder; SUI=Suicide attempt.
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Table 3
Parameter estimates for the three-class solution in 439 individuals with AUD.
Prevalence of indicators among the N=439











Cannabis use disorder 82 (18.7) 0.751 0.133 0.099 C1 > C2,C3⁎⁎⁎
Cocaine use disorder 30 (6.8) 0.548 0.000 0.005 C1 > C3⁎⁎⁎
Other drug use disorders 27 (6.2) 0.497 0.000 0.004 C1 > C3⁎⁎⁎
Major depression 189 (43.1) 0.443 0.721 0.284 C2 > C1,C3⁎⁎⁎
Simple phobia 67 (15.3) 0.127 0.289 0.090 C2 > C1*,C3⁎⁎⁎
Social phobia 68 (15.5) 0.207 0.282 0.081 C1*,C2⁎⁎⁎ > C3
Posttraumatic stress disorder 31 (7.1) 0.088 0.179 0.013 C1⁎⁎,C2⁎⁎⁎ > C3
Separation anxiety disorder 31 (7.1) 0.025 0.167 0.032 C2 > C1*,C3⁎⁎⁎
Other anxiety disorders 41 (9.3) 0.050 0.218 0.041 C2 > C1*,C3⁎⁎⁎
Attention deficit hyperactivity disorder 22 (5.0) 0.056 0.113 0.018 C1*,C2⁎⁎⁎ > C3
Antisocial personality disorder 45 (10.3) 0.438 0.061 0.055 C1 > C2,C3⁎⁎⁎
Suicide attempt 53 (12.1) 0.238 0.222 0.047 C1,C2 > C3⁎⁎⁎
C1=Class1; C2=Class2; C3=Class3.
1 Probability of each indicator among subjects of this class
⁎⁎⁎ p ≤ 0.001
⁎⁎ p ≤ 0.01
⁎ p ≤ 0.05
Table 4
Distributions of sociodemographic characteristics among the three derived classes of AUD comorbidity.
Total sample LOW % DEP-ANX % DD-AS % P-value
Female gender 22.6 0.4 68.3 34.8 <0.001
DEP-ANX,DD-AS > LOW***
DEP-ANX > DD-AS***
Age (M±SD) 50.5± 8.6 51.9± 8.4 49.8± 8.7 43.6± 4.8 <0.001
LOW > DEP-ANX*,DD-AS***
DEP-ANX > DD-AS***
Marital status Single 18.7 13.9 26.7 26.1 <0.001
Married vs. single (Ref.): LOW > DEP-ANX***,DD-
AS**
Married 54.4 64.5 36.7 41.3
Divorced/separated 25.5 20.5 34.2 32.6
Widowed 1.4 1.1 2.5 0.0
Education Compulsory school not completed 1.1 1.1 1.7 0.0 0.817
Obligatory schooling or apprenticeship 59.2 57.9 60.0 65.2
Professional school or technical higher
education
20.3 21.3 17.5 21.7
University-level education 19.4 19.8 20.8 13.0
SES Hollingshead Index (M±SD) 3.3± 1.3 3.4± 1.3 3.2±1.3 3.2± 1.1 0.586
Note: Bold values are statistically significant after Bonferroni's correction; SES = socio-economic status.
Table 5
Psychosocial and genetic risk factors.
Total sample % LOW % DEP-ANX % DD-AS % P-value
Psychosocial risk factors Unhappy childhood 14.6 8.4 24.2 26.1 <0.001
DEP-ANX***,DD-AS** > LOW
Fear to be punished by parents 17.6 11.0 30.0 23.9 <0.001
DEP-ANX***,DD-AS* > LOW
Ran away from home 7.5 6.2 6.7 17.4 0.027
Foster home 12.3 9.2 18.3 15.2 0.032
Grown up without biological parents 37.1 31.5 48.3 41.30 0.005
Parents divorced/separated 18.2 14.3 25.8 21.7 0.019
Low income (< 50,000 CHF per year) 25.8 20.2 34.2 37.0 0.003
Psychopathology in first degree relatives AUD 42.9 39.6 48.1 48.8 0.243
SUD 8.3 6.3 12.3 9.8 0.166
Depression 23.2 22.6 25.8 20.0 0.677
Anxiety disorders 8.3 6.7 12.6 6.7 0.141
Note: Bold values are statistically significant after Bonferroni's correction; AUD = alcohol use disorders; SUD = substance use disorders.
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with AUD, about one fourth had a relative with depression; and more
than one quarter had a rather low income. Except for familial liability,
all other risk factors were more often reported by members from the
DEP-ANX or DD-AS subtypes. However, after Bonferroni's correction
only two factors remained significant: having had an unhappy child-
hood as well as the persistent fear of being punished by their parents
were almost equally linked to DEP-ANX and DD-AS. For more detailed
information on psychosocial risk factors please refer to Table 5.
Table 6 summarizes the distribution of alcohol-related variables
across AUD subtypes. Accordingly, compared to others DD-AS had an
earlier onset of AUD, consumed more pure alcohol daily, reported al-
cohol-related blackouts and symptoms of withdrawal as well as adverse
social consequences resulting from alcohol consumption more often.
Both DEP-ANX and DD-AS reported to self-medicate symptoms of psy-
chological distress through the use of alcohol and higher functional
impairment in important life domains more often than LOW and had
lower overall lifetime GAF scores.
As shown in Table 7, the majority of individuals with AUD had
received professional treatment for mental health problems, those from
the DEP-ANX and DD-AS subtypes even more often than LOW. DEP-
ANX and DD-AS ever used psychotropic medication for mental health
problems approximately twice as often as LOW. Classes did not differ
either in age of first professional help received nor of first hospitaliza-
tion. DD-AS sought non-professional help for alcohol-related problems
in particular more often than the others. For more detailed information
on treatment utilization please refer to Table 7.
Discussion
We analyzed a subsample of individuals with AUD from a large
cross-sectional community survey in the Swiss population to explore
empirical subtypes of AUD based on groups with homogeneous co-
morbidity patterns. Subtypes were derived using LCA and were further
validated based on a range of external criteria including risk factors,
clinical and treatment-related variables.
Results showed that the best-fitting model was a three-class solution
that best describes the variation of comorbidity among individuals with
AUD along latent dimensions termed low (LOW), depressed-anxious
(DEP-ANX), and drug-dependent antisocial (DD-AS) comorbidity. While
LOW contains almost pure AUD cases, i.e. those with no or less co-
morbid conditions, DD-AS was primarily characterized by higher
probabilities for other substance use disorders and antisocial
Table 6
Alcohol use, chronicity, consequences and health-related functioning.
Total sample % LOW % DEP-ANX % DD-AS % P-value
Onset age of AUD in years (M±SD) 29.8± 10.6 30.1± 10.4 31.5± 11.3 23.7±6.6 <0.001
LOW,DEP-ANX > DD-
AS***
Consumption pattern Daily alcohol intake in grams (M±SD) 51.5± 54.5 45.8± 42.9 48.2± 47.7 91.3±99.7 <0.001
DD-AS*** > LOW, DEP-
ANX
Indicators of harmful use Experience of alcohol-related blackouts 36.1 30.9 35.8 67.4 <0.001
DD-AS*** > LOW, DEP-
ANX
Several episodes of binge-drinking 37.3 33.3 38.7 56.5 0.010
Drinking to self-medicate psychological distress 36.9 27.1 51.7 56.5 <0.001
DEP-ANX,DD-AS >
LOW***
Symptoms of withdrawal when not drinking (M±SD) 1.0± 2.1 0.7± 1.7 1.2±2.4 2.0± 3.1 <0.001
DD-AS > LOW**
Physical conditions resulting from alcohol consumption (M±SD) 0.4± 0.8 0.3± 0.8 0.4±0.9 0.6± 1.1 0.103
Social consequences from drinking (M±SD) 0.9± 0.9 0.9± 0.9 0.8±0.9 1.4± 1.0 <0.001
DD-AS > LOW**,DEP-
ANX***
Functionally impaired at school, work or other responsibilities due to mental health
problems at least once in lifetime
28.6 18.0 47.9 41.3 <0.001
DEP-ANX***,DD-AS** >
LOW
GAF Lifetime (M±SD) 68.7± 11.1 71.6± 10.7 65.0± 9.9 61.0±10.0 <0.001
LOW*** > DEP-ANX,DD-
AS
Note: Bold values are statistically significant after Bonferroni's correction; AUD = alcohol use disorders; GAF = Global Assessment of Functioning.
Table 7
Treatment-related variables.
Total sample LOW % DEP-ANX % DD-AS % P-value
Overall treatment
Lifetime professional treatment for mental health problems 57.4 46.9 76.7 69.6 <0.001
DEP-ANX***,DD-AS** > LOW
Age of first professional help for mental health problems in years (M±SD) 33.2± 12.7 35.2± 14.0 30.7± 11.4 32.4± 9.0 0.033
Lifetime use of psychotropic medication for mental health problems 45.3 33.0 69.2 56.5 <0.001
DEP-ANX***,DD-AS** > LOW
Hospitalization for mental health problems 14.8 13.6 12.6 28.3 0.025
Age of first hospitalization for mental health problems in years (M±SD) 37.5± 11.7 38.7± 12.0 38.2± 12.3 32.2± 8.4 0.255
Alcohol-specific treatment
Alcohol-specific treatments 16.2 15.8 15.0 21.7 0.546
Professional treatment 15.0 15.4 13.3 17.4 0.780
Non-professional help-seeking 5.9 5.1 3.3 17.4 0.002
DD-AS** > DEP-ANX, LOW
Note: Bold values are statistically significant after Bonferroni's correction.
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personality disorder, and DEP-ANX was most likely to have comorbid
major depression and anxiety disorders. On the one hand our results
strongly support the validity of the two primary AUD comorbidity di-
mensions of internalizing and externalizing psychopathology, on the
other hand we found evidence that the majority of individuals with
AUD had no or less additional psychopathology.
A pure AUD subtype has been well-described in earlier typologies
(Babor et al., 1992; Cloninger et al., 1981; Del Boca and
Hesselbrock, 1996; Windle and Scheidt, 2004) and shares a number of
characteristics with our findings. Thus, our LOW type contains in-
dividuals with less severe and later-onset AUD, lower impairment, less
risk factors and social and physical consequences. In contrast to those
earlier subtypes, which more or less found both sexes to be equally
affected (e.g. Cloninger et al., 1981; Hill, 1992), was our subtype
completely male-limited. However, it has been shown that males are
more likely to develop AUD without comorbid conditions while females
are more likely to drink to self-medicate psychological distress asso-
ciated with co-occurring psychopathology, especially depressive and/or
anxious symptoms (Dawson et al., 2010). For males, drinking is more
normative and socially acceptable than for females. Males often drink
hazardously just due to peer pressure and are therefore at high risk to
develop independent alcohol problems (Studer et al., 2014). A clinical
study using Babors typology (1992) found a similar proportion of pa-
tients classified as LOW (i.e. termed “Type A” 68% vs. 62% classified as
LOW in the current study) (Bottlender et al., 2006), which supports the
validity of this subtype.
The second-largest subtype, DEP-ANX, in contrast, was more fre-
quent among females, and was characterized by a high association with
depressive and anxiety disorders, a later drinking onset, high functional
impairment and early life adversity. Earlier attempts similarly found
support for a subtype that led to alcohol abuse or dependence through
the path of negative affect and depressive symptoms - often in response
to developmental stressors (Earnshaw et al., 2017; Luk et al., 2010).
Indeed, the self-medication hypothesis (Khantzian, 1985) suggests that
individuals with internalizing problems, such as depression and an-
xiety, begin drinking to “treat” or self-medicate difficult symptoms and
psychological distress associated with the disorder (Bolton et al., 2009;
Robinson et al., 2009). Initially, alcohol may be used to relax, to help
find sleep and to relieve stress and anxiety (Kushner et al., 1994), which
over time, might lead to an independent AUD.
One out of ten individuals with AUD were classified as most affected
(DD-AS), i.e. with highest and most harmful consumption levels as well
as social consequences and functional impairment. This type comprises
predominantly male and rather young individuals with AUD
(Regier et al., 1990). Similar-feature subtypes were suggested in pre-
vious typologies, for example the “Chronic/antisocial subtype”
(Windle and Scheidt, 2004), the “Young antisocial type” (Moss et al.,
2007), or “Externalizing subtype” (Del Boca and Hesselbrock, 1996).
Consistent with those other typologies, DD-AS individuals reported an
AUD onset of lower than 24 years compared to the others with onsets of
30 years and over. In fact, externalizing problems were found to be
specifically linked to an early initiation of drinking (Zernicke et al.,
2010). It has been suggested that early drinking onset is frequently
linked to disinhibitory personality traits, which also activate processes
that are common in other substance use problems and antisocial be-
havior. It might also be possible that higher drug use in this group is an
artifact of younger age, which is up to 8 years lower than the others. In
those with younger age the drug use was socially more acceptable and
even more readily available while, in contrast, older people had rather
limited exposure to drug use during developmental periods when drug
exploration was highest (Golub and Johnson, 2001; Han et al., 2009).
Moreover, this severe AUD subtype was associated with more psycho-
social risk factors and a tendency for an overall higher and more
harmful substance misuse, i.e. more daily alcohol intake and con-
sumption of other drugs. Those individuals are also more likely to ex-
perience serious alcohol-related social consequences and functional
impairment than others. Although our findings are still cross-sectional,
this is compatible with earlier findings that both psychopathological
and psychosocial distress indicators are often precursors of increased
alcohol consumption, and moreover lead to more severe clinical pre-
sentations of AUD (Abler et al., 2014).
Although self-medication is usually associated with accounts of in-
ternalizing problems it was not more often reported by DEP-ANX than
by DD-AS. Indeed, antisocial tendencies or behaviors often co-occur
with AUD as a consequence of the social inhibition- and anxiety- low-
ering effect of alcohol, which makes a person feel more relaxed
(Kushner et al., 2000). Those individuals typically suffer from elevated
levels of behavioral undercontrol; therefore are more likely to benefit
from the stress response dampening effect of alcohol and to effectively
use it as a way to cope with stress (Chassin et al., 2013). Our findings of
high self-medication tendencies in that male-limited subtype were
previously reported by Bolton et al. (2009) who suggested that males
with anti-social personality disorders were likely to self-medicate psy-
chological distress with alcohol while females were not.
Interestingly, our findings suggest a somewhat different AUD-type
composition in the Swiss community compared to reports from abroad
(Glass et al., 2014; Moss et al., 2007). In contrast to other reports, we
found AUD more likely to be linked to internalizing than to ex-
ternalizing comorbid psychopathology. In fact, there is shared epide-
miological support from three population-based studies that inter-
nalizing disorders, especially mood disorders, were found to be more
prevalent in Switzerland (Ajdacic-Gross et al., 2016; Angst et al., 2005;
Rodgers et al., 2015; Vandeleur et al., 2017) than elsewhere
(Kessler et al., 2005). We added evidence that this proportion did not
alter through the co-occurrence of AUD. The somewhat smaller asso-
ciation of AUD with externalizing problems might be due to opposite
trends. Although we found almost similar rates of overall lifetime an-
tisocial personality disorders as reported elsewhere (Compton et al.,
2005), associations with AUD found in the current study were com-
parably smaller (Grant et al., 2015; Guy et al., 2018; Morgenstern et al.,
1997). Moreover, other key indicators of the externalizing spectrum,
such as cannabis and cocaine use disorder, were overall less prevalent
in the current sample (Compton et al., 2005; Grant et al., 2016) as well
as showed weaker associations as reported in other community studies
(Stinson et al., 2006).
Our findings further suggest that AUD comorbidity was associated
with a higher likelihood for suicidality while pure AUD was not. This
supports earlier findings suggesting that the risk for suicidality in-
creases with higher symptom load and greater impairment (Briere et al.,
2014). Although suicidality is primarily associated with internalizing
problems, such as depression and anxiety (Fuehrlein et al., 2016;
Ganz and Sher, 2009), there is increasing scientific evidence showing
that externalizing disorders, such as antisocial personality disorders,
enhance this association as well (Hoertel et al., 2018). Those in-
dividuals typically struggle with poor impulse control, which may make
them vulnerable to participate in risky problematic alcohol and drug
use as well as other self-destructive behaviors (Sher, 2006).
Although there is evidence that genetic factors generally play a
crucial role in the development of AUD (Kendler et al., 2015), we found
no additional support for specific associations of AUD subtypes and
specific family liability, at least to say for AUD, SUD, depression, and
anxiety. Despite overall high prevalence of familial depression and
substantial proportions of anxiety disorders among first degree family
members there were no AUD subtype-specific associations. However,
this is not surprising since there is no clear agreement so far on whether
internalizing (Prescott et al., 2000) or externalizing features
(Cloninger et al., 1981) have a stronger genetic component in the de-
velopment of AUD. Instead, our findings rather suggest that develop-
mental factors have distinct associations with more severe AUD sub-
types. It has been suggested that early adversity, such as an unstable
childhood and familial environment may lead to early initiation and
more severe drinking (Kauhanen et al., 2011). However, it might also
M. Müller, et al. Psychiatry Research 285 (2020) 112712
7
be possible that early developmental factors covary or interact with
genetic factors (Enoch, 2011), which, however was not tested in the
current study.
The majority of individuals with AUD received treatment for mental
health problems at any point of their lives, however, our findings
support the notion that especially individuals with additional comorbid
conditions are even more likely to seek help for their problems than
those with pure AUD (Cohen et al., 2007). Thus, it is quite alarming that
individuals from the DD-AS type, i.e. with early-onset and more severe
AUD, did not seek professional help more often than DEP-ANX and not
earlier than others. An early drinking onset might be associated with a
longer duration of alcohol-related and other mental health problems
and consequently with longer periods of untreated problems. Higher
clinical severity and overall impairment indicate an increased need for
alcohol treatment in those individuals. However, our findings suggest
that individuals with AUD in general less often ever received alcohol-
specific treatment, which may suggest that high numbers of affected
individuals were simply not detected. Individuals from the DD-AS
subtype did not report more alcohol-specific treatments but, however,
higher informal helpseeking for alcohol problems than the others. Thus,
despite greater impairment there is evidence that individuals with co-
morbid antisocial personality and/or substance use disorders often have
poor insight into their problems (Black, 2018) and overall negative
attitudes towards mental health services (Jagdeo et al., 2009), and
therefore were less likely to voluntarily seek alcohol treatment than
others (Goldstein et al., 2010). This, in turn, might explain why those
individuals reported to utilize informal sources of help remarkably
more often. Brown et al. (Brown et al., 2014) found informal help-
seekers more often than formal helpseekers to rate themselves as
healthier and less functionally impaired. Moreover, our broad defini-
tion of informal help might lead to possible misconceptions with be-
haviors such as an association with antisocial peers, which was per-
sonally understood as support but might not be considered as positive
from a health-promoting perspective (Rickwood and Thomas, 2012).
Strengths of the study doubtlessly include a representative, com-
munity-based sample and the use of reliable and valid measures of AUD
and comorbid psychopathology. To our knowledge this is the first study
that systematically examined the complexity of AUD comorbidity in the
Swiss community. As we have found specific etiological as well as other
risk factors, it is important to estimate the prevalence of these factors in
the general population. Future research is needed to understand the
relationship between these factors and alcohol problems to devise ef-
fective interventions. Another strength is the model-based approach
(LCA) used to identify latent subtypes of AUD that qualitatively differ
with respect to their patterns of comorbidity. The fact that the inter-
nalizing and externalizing subtypes differed with respect to etiological
factors lends further support for their discriminant validity.
Despite its strengths, this study has a number of limitations that
have to be acknowledged when interpreting the results. First and most
importantly, the cross-sectional design of our study does not allow us to
draw conclusions regarding causality since results are based on retro-
spectively reported ages of onset. Thus, the use of lifetime diagnoses did
not allow us to determine whether AUD was of primary or secondary
concern within a co-occurrence with other disorders, i.e. whether AUD
was determined by another disorder or was the preceding condition.
Although onsets of comorbid conditions varied across classes, their
prevalences were too low, except for depression, to find significant
differences to determine temporal associations between disorders. Our
results should be replicated in a larger longitudinal sample. Second, our
results are based on data collected more than 10 years ago, which may
not reflect current comorbidity trends but, however, may illustrate the
interrelations of psychiatric conditions co-occurring with AUD. Third,
we did not assess all psychiatric diagnoses but only the most common
ones. Fourth, the use of a non-clinical sample might limit the general-
izability of our findings to clinical samples of individuals with AUD.
Fifth, as psychosocial and developmental adversity were reported
retrospectively, data might be subject to recall bias, especially in sub-
jects of older age. These reports may have been further influenced by
current affective states or other unknown factors that were not assessed
in this study. Therefore, we cannot exclude the possibility that the re-
collection of adverse experiences, rather than the actual experience it-
self, was associated with higher alcohol consumption (patterns) or co-
morbid conditions. Sixth, the fact that younger individuals reported
earlier AUD onsets might also be the consequence of an inaccurate re-
call – a bias that was often observed in cross-sectional data. This effect,
known as “foreward telescoping”, describes the phenomenon of fore-
ward shifting of recalled individual onset ages by increasing ages of the
surveyed subject (Golub et al., 2000). Thus, younger persons sometimes
were placed at risk for early problem use while the same person might
not be identified as at-risk when surveyed at a later age. Therefore,
appropriate caution should be exercised in interpreting these findings.
Future studies should further address these aspects, which extend be-
yond the scope of the present research. Seventh and finally, the semi-
structured interview that was used to determine AUD and comorbid
disorders was based on the diagnostic criteria of DSM-IV while DSM-5 is
now currently in use. Therefore, the presence of DSM-5 AUD and its
associated comorbid conditions needs to be determined in further re-
search.
In sum, this study provides evidence for three AUD subtypes in the
Swiss community that vary along dimensions of comorbidity as well as
clinical and etiological factors with important implications for treat-
ment. The presence of substantial “high impact” comorbidity in in-
dividuals with AUD that do not seek specialized treatment suggests the
need for comprehensive diagnostic assessments at all health service
facilities, regardless of whether one presents for alcohol problems in
specialized mental health or in general medical settings. Low engage-
ment in treatment stresses the need to identify high-risk individuals in
order to develop appropriate strategies to engage this group in treat-
ment for all identified disorders. Identifying specific developmental and
risk factors that are AUD-promoting but potentially modifiable may
present important targets for prevention and early intervention.
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